gvtcx

supplier

Janssen-Cilag Ltd

HP124DP combined from 3 published records

as a supplier

92 recorded awards from 12 buyers , between 10 Aug 2017 and 31 May 2026.

awards won
92
exclusive
9%
8 sole-winner awards
median award
£261.9m
largest
£986.3m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 shared NHS England £813,863,584 31 May 2026
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 shared NHS England £18,903,212 31 May 2026
NHS National Generics Pharmaceuticals - Supply Chain Resilience shared NHS England £35,010,320 30 Apr 2026
NHS National Branded Interim - 1 June 2026 shared NHS England £529,090,780 9 Apr 2026
Transitional Drugs 5 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £5,577,339 25 Nov 2025
NHS National Framework for Golimumab Injection shared NHS England £60,000,000 25 Aug 2025
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 shared NHS England £986,282,758 30 Jun 2025
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared NHS England £261,895,933 24 Jun 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared NHS England £1,241,520,444 24 Mar 2025
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 shared NHS England £626,522,476 28 Oct 2024
CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab shared NHS England £230,000,000 12 Aug 2024
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) shared NHS England £1 4 Mar 2024
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared NHS England £304,504,000 23 Apr 2023
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche shared NHS England £261,970,000 8 Feb 2023
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual shared NHS England £216,078,796 7 Feb 2022
National Procurement for HIV and Preventative Treatments shared NHSE&I £230,000,000 1 Feb 2022
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche shared NHS England £1 11 Feb 2021
NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared NHS England £191,062,951 16 Jun 2020
NHS National Branded Proprietary Products (Interim Agreement) - Contracts Finder Award shared NHS England £54,500,000 30 Apr 2020
NHS Midlands and East Branded Medicines - Tranche A shared NHS England £418,787,000 15 Jan 2020

every contract won by Janssen-Cilag Ltd →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Janssen-Cilag Ltd · HP12 4DP 70
Janssen-Cilag Ltd GB-COH 01027904 HP12 4DP 15
JANSSEN-CILAG LIMITED GB-PPON PTBW-9923-RLZD HP12 4EG 7

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works